How pharmaceutical and diagnostic stakeholders construct policy solutions to a public health 'crisis': an analysis of submissions to a United Kingdom House of Commons inquiry into antimicrobial resistance.

MLA

Glover, Rebecca E., et al. “How Pharmaceutical and Diagnostic Stakeholders Construct Policy Solutions to a Public Health ‘Crisis’: An Analysis of Submissions to a United Kingdom House of Commons Inquiry into Antimicrobial Resistance.” Critical Public Health, vol. 33, no. 2, Apr. 2023, pp. 197–206. EBSCOhost, https://doi.org/10.1080/09581596.2022.2026296.

APA

Glover, R. E., Petticrew, M. P., Mays, N. B., & Thompson, C. (2023). How pharmaceutical and diagnostic stakeholders construct policy solutions to a public health “crisis”: an analysis of submissions to a United Kingdom House of Commons inquiry into antimicrobial resistance. Critical Public Health, 33(2), 197–206. https://doi.org/10.1080/09581596.2022.2026296

Chicago

Glover, Rebecca E., Mark P. Petticrew, Nicholas B. Mays, and Claire Thompson. 2023. “How Pharmaceutical and Diagnostic Stakeholders Construct Policy Solutions to a Public Health ‘Crisis’: An Analysis of Submissions to a United Kingdom House of Commons Inquiry into Antimicrobial Resistance.” Critical Public Health 33 (2): 197–206. doi:10.1080/09581596.2022.2026296.